These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 21731766)
1. Suppression of STAT3 and HIF-1 alpha mediates anti-angiogenic activity of betulinic acid in hypoxic PC-3 prostate cancer cells. Shin J; Lee HJ; Jung DB; Jung JH; Lee HJ; Lee EO; Lee SG; Shim BS; Choi SH; Ko SG; Ahn KS; Jeong SJ; Kim SH PLoS One; 2011; 6(6):e21492. PubMed ID: 21731766 [TBL] [Abstract][Full Text] [Related]
2. Rhapontigenin inhibited hypoxia inducible factor 1 alpha accumulation and angiogenesis in hypoxic PC-3 prostate cancer cells. Jung DB; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Kim YC; Ahn KS; Chen CY; Kim SH Biol Pharm Bull; 2011; 34(6):850-5. PubMed ID: 21628883 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of VEGF expression through blockade of Hif1α and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells. Carbajo-Pescador S; Ordoñez R; Benet M; Jover R; García-Palomo A; Mauriz JL; González-Gallego J Br J Cancer; 2013 Jul; 109(1):83-91. PubMed ID: 23756865 [TBL] [Abstract][Full Text] [Related]
4. 1,2,3,4,6-Penta-O-galloly-beta-D-glucose suppresses hypoxia-induced accumulation of hypoxia-inducible factor-1α and signaling in LNCaP prostate cancer cells. Park KY; Lee HJ; Jeong SJ; Lee HJ; Kim HS; Kim SH; Lim S; Kim HC; Lü J; Kim SH Biol Pharm Bull; 2010; 33(11):1835-40. PubMed ID: 21048308 [TBL] [Abstract][Full Text] [Related]
5. HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas. Gray MJ; Zhang J; Ellis LM; Semenza GL; Evans DB; Watowich SS; Gallick GE Oncogene; 2005 Apr; 24(19):3110-20. PubMed ID: 15735682 [TBL] [Abstract][Full Text] [Related]
6. Sphingosine kinase 1 pathway is involved in melatonin-induced HIF-1α inactivation in hypoxic PC-3 prostate cancer cells. Cho SY; Lee HJ; Jeong SJ; Lee HJ; Kim HS; Chen CY; Lee EO; Kim SH J Pineal Res; 2011 Aug; 51(1):87-93. PubMed ID: 21392092 [TBL] [Abstract][Full Text] [Related]
7. Betulinic acid inhibits the expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in human endometrial adenocarcinoma cells. Karna E; Szoka L; Palka JA Mol Cell Biochem; 2010 Jul; 340(1-2):15-20. PubMed ID: 20174965 [TBL] [Abstract][Full Text] [Related]
8. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha. Forooghian F; Das B Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204 [TBL] [Abstract][Full Text] [Related]
9. Topotecan inhibits vascular endothelial growth factor production and angiogenic activity induced by hypoxia in human neuroblastoma by targeting hypoxia-inducible factor-1alpha and -2alpha. Puppo M; Battaglia F; Ottaviano C; Delfino S; Ribatti D; Varesio L; Bosco MC Mol Cancer Ther; 2008 Jul; 7(7):1974-84. PubMed ID: 18645007 [TBL] [Abstract][Full Text] [Related]
10. Guggulsterone inhibits angiogenesis by blocking STAT3 and VEGF expression in colon cancer cells. Kim ES; Hong SY; Lee HK; Kim SW; An MJ; Kim TI; Lee KR; Kim WH; Cheon JH Oncol Rep; 2008 Dec; 20(6):1321-7. PubMed ID: 19020709 [TBL] [Abstract][Full Text] [Related]
11. Aromatic Hydrocarbon Receptor Suppresses Prostate Cancer Bone Metastasis Cells-Induced Vasculogenesis of Endothelial Progenitor Cells under Hypoxia. Huang S; Guo Y; Jacobi A; Li Z; Huang S; He J; Liu X; Tang Y Cell Physiol Biochem; 2016; 39(2):709-20. PubMed ID: 27448695 [TBL] [Abstract][Full Text] [Related]
12. Suppression of HIF-1α accumulation by betulinic acid through proteasome activation in hypoxic cervical cancer. Kim HJ; Cho HS; Ban HS; Nakamura H Biochem Biophys Res Commun; 2020 Mar; 523(3):726-732. PubMed ID: 31948750 [TBL] [Abstract][Full Text] [Related]
13. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells. Chen MC; Lee CF; Huang WH; Chou TC Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116 [TBL] [Abstract][Full Text] [Related]
14. HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs). De Francesco EM; Lappano R; Santolla MF; Marsico S; Caruso A; Maggiolini M Breast Cancer Res; 2013; 15(4):R64. PubMed ID: 23947803 [TBL] [Abstract][Full Text] [Related]
15. A novel inhibitor of hypoxia-inducible factor-1α P3155 also modulates PI3K pathway and inhibits growth of prostate cancer cells. Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Sonawane V; Rathos MJ; Kumar S; Joshi KS BMC Cancer; 2011 Aug; 11():338. PubMed ID: 21819554 [TBL] [Abstract][Full Text] [Related]
16. Anti-cancer effect of pristimerin by inhibition of HIF-1α involves the SPHK-1 pathway in hypoxic prostate cancer cells. Lee SO; Kim JS; Lee MS; Lee HJ BMC Cancer; 2016 Aug; 16(1):701. PubMed ID: 27581969 [TBL] [Abstract][Full Text] [Related]
17. A novel regulation of VEGF expression by HIF-1α and STAT3 in HDM2 transfected prostate cancer cells. Rathinavelu A; Narasimhan M; Muthumani P J Cell Mol Med; 2012 Aug; 16(8):1750-7. PubMed ID: 22004076 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory action of Celastrol on hypoxia-mediated angiogenesis and metastasis via the HIF-1α pathway. Huang L; Zhang Z; Zhang S; Ren J; Zhang R; Zeng H; Li Q; Wu G Int J Mol Med; 2011 Mar; 27(3):407-15. PubMed ID: 21249310 [TBL] [Abstract][Full Text] [Related]
19. miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells. Cascio S; D'Andrea A; Ferla R; Surmacz E; Gulotta E; Amodeo V; Bazan V; Gebbia N; Russo A J Cell Physiol; 2010 Jul; 224(1):242-9. PubMed ID: 20232316 [TBL] [Abstract][Full Text] [Related]
20. Hypoxia effects on proangiogenic factors in human umbilical vein endothelial cells: functional role of the peptide somatostatin. Dal Monte M; Martini D; Ristori C; Azara D; Armani C; Balbarini A; Bagnoli P Naunyn Schmiedebergs Arch Pharmacol; 2011 Jun; 383(6):593-612. PubMed ID: 21523559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]